Cerebral Palsy Clinical Trial
Official title:
“DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?”
In children with cerebral palsy, stiffness of the arm can develop early and delay or prevent the acquisition of normal hand skills. Improvement in functional use of the hand may therefore be dependent upon early treatment of upper extremity hypertonia. We propose to test a series of injections of Myobloc™ in a non-randomized one-way crossover pilot clinical trial and dose-finding study, with clinical assessments and blinded video evaluations. Ten children age 2-17 years with increased tone at the elbow or wrist will be expected to complete the study. A 1-month baseline evaluation period will be followed by an injection of low-dose Myobloc™ to affected muscle(s) of the arm according to standardized per-kilogram dosing with a maximum of 25U/kg in each affected arm. Three months later, a second injection of up to 50U/kg will be performed in each affected arm. Three months after the second dose, a third dose of up to 100U/kg will be performed in each affected arm. Neurological assessments will be performed at study entry, prior to each injection, and at 1 and 3 months following each injection. Routine physical therapy and non-study medications will be continued during the study.
Subjects: 10 subjects age 2-17 years with hypertonia affecting one or both upper
extremities, but without injections of neuromuscular blocking agents for six months prior to
enrollment, or surgery on the upper extremity.
Intervention: Injection of Myobloc™ in 2 sites per muscle for up to two muscles of each
upper extremity (biceps, brachioradialis), at a maximum dose of 25Units/kg/arm for the first
injection, a maximum of 50Units/kg/arm for the second injection, and a maximum of
100Units/kg/arm for the third injection. If there is significant weakness or worsening of
function following any injection, the dose will not be increased for subsequent injections.
Injections will be performed after placement of topical anesthetic (ELA-MAX™ cream), using
EMG guidance to identify active muscles contributing to hypertonia.
Primary outcome measures: The primary outcome measure is the time it takes to complete
maximum arm extension during voluntary reaching, measured from the coraco-acromial joint to
the midpoint of the dorsum of the wrist. Change scores will be calculated between intake and
1 month (baseline effect), 1 month and 2 months (first injection effect), 4 months and 5
months (second injection effect), and 7 months and 8 months (third injection effect). A
device called a Shape Tape (Measureand, Inc.) will be used to measure this outcome. Shape
Tape is a flexible strip of portable spring steel with optic fiber that provides
instantaneous readouts to a portable computer of bends and twists and other forms of
movement capture that can be conducted in a clinical setting. The Shape Tape is fastened
loosely to the body part under measurement (in this case, the subject’s wrist and shoulder)
with either medical-grade adhesive tape or Velcro. The shapetape is connected to a portable
computer, and custom software allows measurement of the average velocity of hand movement
during reaching.
Secondary outcome measures: The rater will compare improvement or worsening in global arm
function through the Unified Dystonia Rating Scale (UDRS), the motor subscale of the Unified
Parkinson’s Disease rating scale (UPDRS), and the Burke-Fahn-Marsden dystonia scale (BFM).
Comparisons will be performed between intake and 1 month (baseline effect), 1 month and 2
months (first injection effect), 4 months and 5 months (second injection effect), and 7
months and 8 months (third injection effect). Other secondary measures include neurological
examination, Ashworth spasticity scale, and comparisons of numerical stiffness measures as
measured by the Rigidity Analyzer Device. A parent rating scale, the Pediatric Quality of
Life Inventory (PedsQL), will be used to determine overall functional improvement.
Statistical analysis: The outcomes will be tested at the 0.05 level of significance using
repeated-measures analysis of variance (ANOVA) and the Friedman nonparametric test applied
to the 4 repeated change scores for each of the primary and secondary outcome measures.
Tests of significance for the secondary measures will be corrected for multiple comparisons.
;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05317234 -
Genetic Predisposition in Cerebral Palsy
|
N/A | |
Recruiting |
NCT05576948 -
Natural History of Cerebral Palsy Prospective Study
|
||
Completed |
NCT04119063 -
Evaluating Wearable Robotic Assistance on Gait
|
Early Phase 1 | |
Completed |
NCT03264339 -
The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy
|
N/A | |
Completed |
NCT05551364 -
Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT03902886 -
Independent Walking Onset of Children With Cerebral Palsy
|
||
Recruiting |
NCT05571033 -
Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy
|
N/A | |
Not yet recruiting |
NCT04081675 -
Compliance in Children With Cerebral Palsy Supplied With AFOs
|
||
Completed |
NCT02167022 -
Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy
|
N/A | |
Completed |
NCT04012125 -
The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy
|
N/A | |
Enrolling by invitation |
NCT05619211 -
Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities
|
Phase 1 | |
Completed |
NCT04489498 -
Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
|
||
Completed |
NCT03677193 -
Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy
|
N/A | |
Recruiting |
NCT06450158 -
Robot-assisted Training in Children With CP
|
N/A | |
Completed |
NCT04093180 -
Intensive Neurorehabilitation for Cerebral Palsy
|
N/A | |
Completed |
NCT02909127 -
The Pediatric Eating Assessment Tool
|
||
Not yet recruiting |
NCT06377982 -
Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy
|
Phase 1 | |
Not yet recruiting |
NCT06007885 -
Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.
|
N/A | |
Not yet recruiting |
NCT03183427 -
Corpus Callosum Size in Patients With Pineal Cyst
|
N/A | |
Active, not recruiting |
NCT03078621 -
Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy
|
Phase 1/Phase 2 |